Paul L. Hallenbeck
Founder at Seneca Therapeutics, Inc.
Paul L. Hallenbeck active positions
| Companies | Position | Start | End |
|---|---|---|---|
Seneca Therapeutics, Inc.
 Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seneca Therapeutics, Inc. operates as a biotechnology company. It develops novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. The company was founded by Paul L. Hallenbeck and is headquartered in Blue Bell, PA. | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| Founder | - | - | |
| President | - | - | |
| Chief Executive Officer | - | - |
Career history of Paul L. Hallenbeck
Former positions of Paul L. Hallenbeck
| Companies | Position | Start | End |
|---|---|---|---|
Synbody Biotechnology, Inc.
 Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Director/Board Member | 2009-12-31 | 2012-12-31 |
| Chief Executive Officer | 2009-12-31 | 2012-12-31 | |
| Founder | 2009-12-31 | 2012-12-31 | |
| President | 2009-12-31 | - | |
| Nisco International Ltd. | President | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 2011-02-21 | - |
Neotropix, Inc.
 Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Chief Tech/Sci/R&D Officer | 2002-12-31 | - |
| Founder | 2002-12-31 | - | |
| President | 2010-02-15 | - |
Training of Paul L. Hallenbeck
| Siena College | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
Operational
| President | 4 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Neotropix, Inc.
Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Synbody Biotechnology, Inc.
Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Health Technology |
Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seneca Therapeutics, Inc. operates as a biotechnology company. It develops novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. The company was founded by Paul L. Hallenbeck and is headquartered in Blue Bell, PA. | Commercial Services |
| Nisco International Ltd. |
- Stock Market
- Insiders
- Paul L. Hallenbeck
- Experience
